Related Experiment Video
Updated: Jan 20, 2026

Double Labeling Immunofluorescence using Antibodies from the Same Species to Study Host-Pathogen Interactions
Published on: July 10, 2021
Host-Pathogen Relationship Advice: Fat Protects against a Broken Heart
Justin L McCarville1, Janelle S Ayres1
1Molecular and Systems Physiology Laboratory, Gene Expression Laboratory, The Nomis Center for Immunobiology and Microbial Pathogenesis, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Growth differentiation factor 15 (GDF15) regulates disease tolerance during infection. This protein protects host health and prevents cardiac damage by coordinating communication between organs through the sympathetic and metabolic systems.
Area of Science:
- Immunology
- Pathophysiology
- Endocrinology
Background:
- Disease tolerance is a host survival strategy that maintains health during infection without eliminating the pathogen.
- Understanding the molecular mechanisms of disease tolerance is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To identify key regulators of disease tolerance during bacterial and viral infections.
- To elucidate the role of Growth Differentiation Factor 15 (GDF15) in mediating disease tolerance and preventing organ damage.
Main Methods:
- The study by Luan et al. (2019) likely involved in vivo infection models (bacterial and viral).
- Investigated the function of GDF15 in regulating host responses and organ protection.
- Explored the downstream signaling pathways involving the sympathetic and metabolic systems.
Main Results:
- GDF15 was identified as a central regulator of disease tolerance.
- GDF15 protected host health against both bacterial and viral challenges.
- GDF15 was shown to prevent cardiac damage during infection.
- GDF15 mediated cross-organ communication through the sympathetic and metabolic systems.
Conclusions:
- GDF15 is a critical mediator of disease tolerance, promoting host survival and organ integrity during infection.
- Targeting GDF15 or its downstream pathways could represent a novel therapeutic approach for managing infectious diseases and their complications.
Related Concept Videos
07:35Double Labeling Immunofluorescence using Antibodies from the Same Species to Study Host-Pathogen Interactions
05:37Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
07:58Use of Image Cytometry for Quantification of Pathogenic Fungi in Association with Host Cells
09:17Use of an Optical Trap for Study of Host-Pathogen Interactions for Dynamic Live Cell Imaging
08:52Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
10:27In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

